Literature DB >> 34291681

Antibiotic Use and Associated Risk Factors for Antibiotic Prescribing in COVID-19 Hospitalized Patients.

Alysa J Martin1, Stephanie Shulder1, David Dobrzynski2, Katelyn Quartuccio1, Kelly E Pillinger1.   

Abstract

BACKGROUND: Literature suggests that antibiotic prescribing in COVID-19 patients is high. Currently, there are insufficient data on what drives antibiotic prescribing practices throughout the COVID-19 pandemic.
OBJECTIVE: This study sought to determine antibiotic use rates and identify risk factors for antibiotic prescribing in hospitalized patients. It was the first study to assess risk factors for receiving more than 1 course of antibiotics.
METHODS: This was a retrospective, multi-center, observational study. Patients admitted from March 1, 2020, to May 31, 2020, and treated for COVID-19 were included. The primary endpoint was the rate of antibiotic use during hospitalization. Secondary endpoints included risk factors associated with antibiotic use, risk factors associated with receiving more than 1 antibiotic course, and rate of microbiologically confirmed infections.
RESULTS: A total of 208 encounters (198 patients) were included in the final analysis. Eighty-three percent of patients received at least 1 course of antibiotics, despite low rates of microbiologically confirmed infection (12%). Almost one-third of patients (30%) received more than 1 course of antibiotics. Risk factors identified for both antibiotic prescribing and receiving more than 1 course of antibiotics included increased hospital length of stay (median 12 days), intensive care unit admission, and the necessity for mechanical ventilation. CONCLUSION AND RELEVANCE: There were high rates of antibiotic prescribing with low rates of microbiologically confirmed bacterial co-infection. Many patients received more than 1 course of antibiotics during hospitalization. This study highlights the importance and demand for appropriate antibiotic stewardship practices in COVID-19 patients.

Entities:  

Keywords:  COVID-19; antibiotics; antimicrobial stewardship; bacterial infection; bacterial pneumonia

Year:  2021        PMID: 34291681     DOI: 10.1177/08971900211030248

Source DB:  PubMed          Journal:  J Pharm Pract        ISSN: 0897-1900


  6 in total

1.  In-Hospital Antibiotic Use for COVID-19: Facts and Rationales Assessed through a Mixed-Methods Study.

Authors:  Laura Elena Stoichitoiu; Larisa Pinte; Alexandr Ceasovschih; Roxana Carmen Cernat; Nicoleta Dorina Vlad; Vlad Padureanu; Laurentiu Sorodoc; Adriana Hristea; Adrian Purcarea; Camelia Badea; Cristian Baicus
Journal:  J Clin Med       Date:  2022-06-02       Impact factor: 4.964

2.  The landscape of antibiotic usage among COVID-19 patients in the early phase of pandemic: a Malaysian national perspective.

Authors:  Izzati-Nadhirah Mohamad; Calvin Ke-Wen Wong; Chii-Chii Chew; E-Li Leong; Biing-Horng Lee; Cheng-Keat Moh; Komalah Chenasammy; Steven Chee-Loon Lim; Hong-Bee Ker
Journal:  J Pharm Policy Pract       Date:  2022-01-11

Review 3.  Cropping Up Crisis at the Nexus Between COVID-19 and Antimicrobial Resistance (AMR) in Africa: A Scoping Review and Synthesis of Early Evidence.

Authors:  Girma Gutema; Gadissa Homa
Journal:  Cureus       Date:  2022-01-08

4.  Antibiotic Use in Suspected and Confirmed COVID-19 Patients Admitted to Health Facilities in Sierra Leone in 2020-2021: Practice Does Not Follow Policy.

Authors:  Ibrahim Franklyn Kamara; Ajay M V Kumar; Anna Maruta; Bobson Derrick Fofanah; Charles Kuria Njuguna; Steven Shongwe; Francis Moses; Sia Morenike Tengbe; Joseph Sam Kanu; Sulaiman Lakoh; Alie H D Mansaray; Kalaiselvi Selvaraj; Mohammed Khogali; Rony Zachariah
Journal:  Int J Environ Res Public Health       Date:  2022-03-28       Impact factor: 3.390

5.  Bacterial infections and antibiotic utilization varies by coronavirus disease 19 (COVID-19) severity in hospitalized cancer patients: Analysis from the first phase of the pandemic.

Authors:  Susan K Seo; Nina Cohen; Kayla R Maki; Samantha N Steiger; Yiqi Su; Aida Boumiza; Carrie A Tan; Marina Kerpelev
Journal:  Infect Control Hosp Epidemiol       Date:  2022-05-26       Impact factor: 6.520

6.  Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis.

Authors:  Faisal Salman Alshaikh; Brian Godman; Oula Nawaf Sindi; R Andrew Seaton; Amanj Kurdi
Journal:  PLoS One       Date:  2022-08-01       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.